Treatment-resistant atopic dermatitis.
Wergowske
G L
GL
D000085:Acetates / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000982:Antipruritics / Q000627:therapeutic use*; D003521:Cyclopropanes; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use*; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides; D017211:Treatment Failure
D000085:Acetates; D000893:Anti-Inflammatory Agents; D000982:Antipruritics; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D006919:Hydroxyzine; C093875:montelukast; D011241:Prednisone